EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, G.
Right arrow Articles by Li, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, G.
Right arrow Articles by Li, Y.

Eur J Cardiothorac Surg 1999;15:653-657
© 1999 Elsevier Science NL


Ischemic preconditioning improves preservation with cold blood cardioplegia in valve replacement patients

Guohu Li, Shenxi Chen, Erxiong Lu, Yuanjian Li

Department of Cardiothoracic Surgery, Xiangya Hospital, Hunan Medical University, Changsha 410008, Hunan, PR China

Received 12 October 1998; received in revised form 26 January 1999; accepted 2 February 1999.

Corresponding author. Tel.: +86-731-413-7154; fax: +86-731-447-1339; e-mail: guohu-li@public.cs.hn.cn

Objective: The purpose of this study was to test the hypothesis that ischemic preconditioning improves myocardial protection in valve replacement patients undergoing cold-blood cardioplegic arrest and to study the mechanisms of human myocardial ischemic preconditioning initially. Methods: Forty patients who required double valve replacement were studied. After the institution of cardiopulmonary bypass, 20 patients were preconditioned with two cycles of 3 min of aortic cross-clamping and 2 min of reperfusion before cardioplegic arrest (group IP). Twenty patients were not preconditioned as controls (group C). All hearts were arrested with 4°C cold-blood cardioplegic solution. During perioperation, the blood samples were collected from coronary sinus and radial artery, which were used to measure calcitonin gene-related peptide (CGRP) and creatine kinase-MB (CK-MB). The right atrial myocardial tissue was collected to measure superoxide dismutase/malondialdehyde (T-SOD/MDA) and to observe myocardial ultrastructure. Hemodynamic date were measured. Results: After reperfusion for 30 min, myocardial MDA was significantly lower in group IP than in group C (2.6±0.2 vs. 3.8±0.3 nM/mg) and T-SOD was significantly higher in group IP than in group C (13.1±12.1 vs. 9.2±1.2 IU/mg). Ischemic preconditioning significantly increased the production of myocardial CGRP just after preconditioning (92.0±4.1 vs. 52.3±4.5 pg/ml) and the begin of reperfusion (95.3±3.8 vs. 61.2±4.9 pg/ml), and deduced the release of CK-MB at 12 h post-reperfusion (77.5±9.2 vs. 136.5±8.9 IU/l). Preconditioning also improved cardiac function at 30 min and 12 h after reperfusion (cardiac index 2.8±0.3 vs. 2.3±0.2 l/min per m2 and 2.9±0.1 vs. 2.4±0.2 l/min per m2). Conclusions: Ischemic preconditioning enhance cardioplegic protection in valve replacement patients. The possible protective mechanism was that ischemic preconditioning decreased the production of oxygen free radicals.

Key Words: Ischemic preconditioning • Calcitonin gene-related peptide • Oxygen free radical • Cardiac surgery




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
D. M. YELLON and J. M. DOWNEY
Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology
Physiol Rev, October 1, 2003; 83(4): 1113 - 1151.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
E. o. Cosar and C. J. O'Connor
Hibernation, Stunning, and Preconditioning: Historical Perspective, Current Concepts, Clinical Applications, and Future Implications
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2003; 7(2): 115 - 140.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Vaage and G. Valen
Preconditioning and cardiac surgery
Ann. Thorac. Surg., February 1, 2003; 75(2): S709 - 714.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
R. Kato and P. Foex
Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists: [La protection myocardique contre les lesions d'ischemie-reperfusion par des anesthesiques : une mise a jour pour les anesthesiologistes]
Can J Anesth, October 1, 2002; 49(8): 777 - 791.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L.K.K. Teoh, R. Grant, J.A. Hulf, W.B. Pugsley, and D.M. Yellon
The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery
Cardiovasc Res, January 1, 2002; 53(1): 175 - 180.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Z.-K. Wu, E. Pehkonen, J. Laurikka, L. Kaukinen, E. L. Honkonen, S. Kaukinen, P. Laippala, and M. R. Tarkka
The protective effects of preconditioning decline in aged patients undergoing coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 972 - 978.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. M. Yellon and A. Dana
The Preconditioning Phenomenon : A Tool for the Scientist or a Clinical Reality?
Circ. Res., September 29, 2000; 87(7): 543 - 550.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.